Jack W. Hsu

发表

Viral Infections in Patients with Hematological Malignancies

John W. Hiemenz, John R. Wingard, Jack W. Hsu, 2013 .

Hematopoietic stem-cell transplantation for advanced systemic mastocytosis.

L. Pagano, M. Perales, I. Yakoub-Agha, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromes.

M. Norkin, W. Wood, M. Sorror, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Uric Acid and the Prediction Models of Tumor Lysis Syndrome in AML

Richard J. Johnson, R. Mohandas, N. Pourafshar, 2015, PloS one.

Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT

M. Norkin, W. Wood, J. Snowden, 2016, Bone Marrow Transplantation.

Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning.

M. Sorror, J. Wingard, U. Popat, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Avascular necrosis of bone after allogeneic hematopoietic cell transplantation in children and adolescents.

W. Wood, M. Sorror, H. Lazarus, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients

H. Kantarjian, G. Garcia-Manero, J. Cortes, 2020, Leukemia & lymphoma.

Elderly Donors in Transplantation

M. Mendizabal, A. Shaked, Jack W. Hsu, 2011 .

Efficacy of micafungin for the treatment of invasive candidiasis and candidaemia in patients with neutropenia

B. Sirohi, N. Seibel, P. Chandrasekar, 2018, Mycoses.

Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphoma.

S. Montoto, P. Hari, D. Maloney, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.

S. Montoto, Sonali M. Smith, P. Hari, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of bryostatin 1 and vincristine for aggressive non‐Hodgkin lymphoma relapsing after an autologous stem cell transplant

M. Schluchter, J. Jacobberger, A. Dowlati, 2009, American journal of hematology.

Autologous and allogeneic transplantation for burkitt lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transplant research.

S. Montoto, P. Hari, D. Maloney, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ALTERNATIVE DONORS EXTEND TRANSPLANTATION FOR PATIENTS WITH LYMPHOMA WHO LACK AN HLA MATCHED DONOR

S. Montoto, Sonali M. Smith, D. Maloney, 2014, Bone Marrow Transplantation.

Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.

B. Storer, K. van Besien, Stephanie J. Lee, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Advances in the management of viral infections.

J. Wingard, Jack W. Hsu, J. Hsu, 2014, Cancer treatment and research.

Viral Infections in Patients with Hematological Malignancies

J. Wingard, J. Hiemenz, Jack W. Hsu, 2013 .

Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial.

A. Krishnan, G. Lozanski, M. Horowitz, 2016, Blood.

Shorter Interdonation Interval Contributes to Lower Cell Counts in Subsequent Stem Cell Donations.

D. Stroncek, B. Shaw, G. Switzer, 2021, Transplantation and cellular therapy.

Weighty choices: selecting optimal G-CSF doses for stem cell mobilization to optimize yield.

J. Wingard, T. Spitzer, B. Shaw, 2020, Blood advances.

Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysis.

J. Wingard, B. Shaw, H. Lazarus, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Association of mannose-binding lectin levels and invasive fungal disease in hematologic malignancy patients receiving myelosuppressive chemotherapy or allogeneic hematopoietic stem cell transplantation

J. Wingard, M. Sugrue, D. Neal, 2016, Bone Marrow Transplantation.

Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.

Tao Wang, Thomas Spitzer, Daniel J Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research.

P. Hari, R. Gale, M. Cairo, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The role of monoclonal antibodies in the treatment of lymphomas

N. Dang, Jack W. Hsu, J. Hsu, 2013, Expert opinion on biological therapy.

Outcomes of human leukocyte antigen-matched sibling donor hematopoietic cell transplantation in chronic lymphocytic leukemia: myeloablative versus reduced-intensity conditioning regimens.

J. Cortes, M. Aljurf, I. Lewis, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes of HLA Matched Sibling Donor Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia: Myeloablative vs. Reduced-Intensity Conditioning Regimens

J. Cortes, M. Aljurf, I. Lewis, 2014 .

Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia.

U. Popat, M. Kalaycio, Z. DeFilipp, 2018, Blood advances.

Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT.

S. Grupp, D. Porter, M. Pasquini, 2014, Blood.

Minimal residual disease by either flow cytometry or cytogenetics prior to an allogeneic hematopoietic stem cell transplant is associated with poor outcome in acute myeloid leukemia

M. Norkin, Y. Li, R. Hromas, 2017, Blood Cancer Journal.

Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology.

J. Wingard, J. Hiemenz, Jack W. Hsu, 2010, Infectious disease clinics of North America.

Effect of melphalan 140 mg/m2 vs 200 mg/m2 on toxicities and outcomes in multiple myeloma patients undergoing single autologous stem cell transplantation—a single center experience

M. Norkin, J. Wingard, Myron N. Chang, 2016, Clinical transplantation.

Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation.

J. Vose, S. Montoto, Sonali M. Smith, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pharmacokinetic and clinical outcomes when ideal body weight is used to dose busulfan in obese hematopoietic stem cell transplant recipients

Jack W. Hsu, H. Murthy, J. Hsu, 2018, Bone Marrow Transplantation.

Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma.

J. Vose, M. Aljurf, R. Gale, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia

O. Frankfurt, S. Kambhampati, H. Kantarjian, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of Romyelocel-L Myeloid Progenitor Cells to Decrease Infections in De Novo AML Patients Receiving High-Dose Ara-C-Based Induction Therapy

S. Kambhampati, H. Kantarjian, T. Kadia, 2018, Blood.

Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.

J. Cortes, M. Aljurf, M. Tallman, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Alternate donor hematopoietic cell transplantation (HCT) in non-Hodgkin lymphoma using lower intensity conditioning: a report from the CIBMTR.

S. Montoto, P. Hari, R. Gale, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Dietary intake and Diet Quality of Hematopoietic Stem Cell Transplant Survivors.

J. Wingard, W. May, D. Kelly, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Late effects in hematopoietic cell transplant recipients with acquired severe aplastic anemia: a report from the late effects working committee of the center for international blood and marrow transplant research.

W. Wood, M. Sorror, M. Aljurf, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Increased Early Graft Failure in Right-Sided Living Donor Nephrectomy

P. Reese, A. Naji, M. Levine, 2011, Transplantation.

Quality of life, social challenges, and psychosocial support for long-term survivors after allogeneic hematopoietic stem-cell transplantation.

M. Norkin, J. Wingard, Jack W. Hsu, 2012, Seminars in hematology.

Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 Trial

C. Hofmeister, A. Krishnan, W. Wachsman, 2021, Frontiers in Immunology.

A Phase II Study of Allogeneic Transplantation for Older Patients with AML in First Complete Remission Using a Reduced Intensity Conditioning Regimen: Results From CALGB 100103/BMT CTN 0502

K. Owzar, R. Vij, R. Larson, 2012 .

Hypomethylating agent induction therapy followed by hematopoietic cell transplantation is feasible in patients with myelodysplastic syndromes.

J. Wingard, C. Cogle, Jack W. Hsu, 2010, Clinical advances in hematology & oncology : H&O.

Elevated incidence of chronic myeloid leukaemia in immunosuppressed solid organ transplant recipients

M. Norkin, J. Wingard, Myron N. Chang, 2014, British journal of haematology.

Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survival.

Alan M. Miller, R. Vij, M. Aljurf, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients.

M. Norkin, Subharup Guha, J. Wingard, 2019, Blood advances.